Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 357

1.

5-HT(1A) receptor function in major depressive disorder.

Savitz J, Lucki I, Drevets WC.

Prog Neurobiol. 2009 May;88(1):17-31. doi: 10.1016/j.pneurobio.2009.01.009. Review.

2.

Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.

Savitz J, Drevets WC.

Neurosci Biobehav Rev. 2009 May;33(5):699-771. doi: 10.1016/j.neubiorev.2009.01.004. Review.

3.

High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding.

Frokjaer VG, Vinberg M, Erritzoe D, Svarer C, Baaré W, Budtz-Joergensen E, Madsen K, Madsen J, Kessing LV, Knudsen GM.

Neuroimage. 2009 Jun;46(2):360-6. doi: 10.1016/j.neuroimage.2009.02.008.

PMID:
19233297
4.

Depressed adolescents demonstrate greater subgenual anterior cingulate activity.

Yang TT, Simmons AN, Matthews SC, Tapert SF, Frank GK, Bischoff-Grethe A, Lansing AE, Wu J, Brown GG, Paulus MP.

Neuroreport. 2009 Mar 4;20(4):440-4. doi: 10.1097/WNR.0b013e3283262e10.

5.

Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety.

Gatt JM, Nemeroff CB, Dobson-Stone C, Paul RH, Bryant RA, Schofield PR, Gordon E, Kemp AH, Williams LM.

Mol Psychiatry. 2009 Jul;14(7):681-95. doi: 10.1038/mp.2008.143.

PMID:
19153574
6.

Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety.

Fakra E, Hyde LW, Gorka A, Fisher PM, Muñoz KE, Kimak M, Halder I, Ferrell RE, Manuck SB, Hariri AR.

Arch Gen Psychiatry. 2009 Jan;66(1):33-40. doi: 10.1001/archpsyc.66.1.33.

7.

A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety.

Furmark T, Appel L, Henningsson S, Ahs F, Faria V, Linnman C, Pissiota A, Frans O, Bani M, Bettica P, Pich EM, Jacobsson E, Wahlstedt K, Oreland L, Långström B, Eriksson E, Fredrikson M.

J Neurosci. 2008 Dec 3;28(49):13066-74. doi: 10.1523/JNEUROSCI.2534-08.2008.

8.

Dopamine in amygdala gates limbic processing of aversive stimuli in humans.

Kienast T, Hariri AR, Schlagenhauf F, Wrase J, Sterzer P, Buchholz HG, Smolka MN, Gründer G, Cumming P, Kumakura Y, Bartenstein P, Dolan RJ, Heinz A.

Nat Neurosci. 2008 Dec;11(12):1381-2. doi: 10.1038/nn.2222.

PMID:
18978778
9.

Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo.

Mickey BJ, Ducci F, Hodgkinson CA, Langenecker SA, Goldman D, Zubieta JK.

J Neurosci. 2008 Oct 29;28(44):11354-9. doi: 10.1523/JNEUROSCI.2391-08.2008.

10.

Amygdala function and 5-HTT gene variants in adolescent anxiety and major depressive disorder.

Lau JY, Goldman D, Buzas B, Fromm SJ, Guyer AE, Hodgkinson C, Monk CS, Nelson EE, Shen PH, Pine DS, Ernst M.

Biol Psychiatry. 2009 Feb 15;65(4):349-55. doi: 10.1016/j.biopsych.2008.08.037.

11.

Depression-related variation in brain morphology over 3 years: effects of stress?

Frodl TS, Koutsouleris N, Bottlender R, Born C, Jäger M, Scupin I, Reiser M, Möller HJ, Meisenzahl EM.

Arch Gen Psychiatry. 2008 Oct;65(10):1156-65. doi: 10.1001/archpsyc.65.10.1156.

PMID:
18838632
12.

Serotonergic genes and amygdala activity in response to negative affective facial stimuli in Korean women.

Lee BT, Ham BJ.

Genes Brain Behav. 2008 Nov;7(8):899-905. doi: 10.1111/j.1601-183X.2008.00429.x.

13.

Seasonal variation in human brain serotonin transporter binding.

Praschak-Rieder N, Willeit M, Wilson AA, Houle S, Meyer JH.

Arch Gen Psychiatry. 2008 Sep;65(9):1072-8. doi: 10.1001/archpsyc.65.9.1072.

PMID:
18762593
14.

Variation in the serotonin transporter gene modulates selective attention to threat.

Osinsky R, Reuter M, Küpper Y, Schmitz A, Kozyra E, Alexander N, Hennig J.

Emotion. 2008 Aug;8(4):584-8. doi: 10.1037/a0012826.

PMID:
18729589
15.

Influence of vascular endothelial growth factor variation on human hippocampus morphology.

Blumberg HP, Wang F, Chepenik LG, Kalmar JH, Edmiston E, Duman RS, Gelernter J.

Biol Psychiatry. 2008 Nov 15;64(10):901-3. doi: 10.1016/j.biopsych.2008.07.003.

16.

Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder.

Chepenik LG, Fredericks C, Papademetris X, Spencer L, Lacadie C, Wang F, Pittman B, Duncan JS, Staib LH, Duman RS, Gelernter J, Blumberg HP.

Neuropsychopharmacology. 2009 Mar;34(4):944-51. doi: 10.1038/npp.2008.107.

17.

The subgenual anterior cingulate cortex in mood disorders.

Drevets WC, Savitz J, Trimble M.

CNS Spectr. 2008 Aug;13(8):663-81. Review.

18.

Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.

Boileau I, Warsh JJ, Guttman M, Saint-Cyr JA, McCluskey T, Rusjan P, Houle S, Wilson AA, Meyer JH, Kish SJ.

Mov Disord. 2008 Sep 15;23(12):1776-80. doi: 10.1002/mds.22212.

PMID:
18661545
19.

GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes.

Poulter MO, Du L, Weaver IC, Palkovits M, Faludi G, Merali Z, Szyf M, Anisman H.

Biol Psychiatry. 2008 Oct 15;64(8):645-52. doi: 10.1016/j.biopsych.2008.05.028.

PMID:
18639864
20.
Items per page

Supplemental Content

Support Center